Clinical management of skin and soft tissue infections in the emergency department of a suburban hospital

Advanced Emergency Nursing Journal

Volumn 32, Issue 2, 2010, Pages 155-167

  Winstead, Yvette ^b,c   Emmerich, Harry ^c   Manning, Mary Lou ^a   Winstead, Denita ^d   Nelson Bachmann, Patrice ^e   Kornecki, Zbigniew ^c  

^a Jefferson School of Nursing   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c Aria Health Hospital   (United States)

^d JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^e Department of Emergency Medicine ^*  (United States)

Author keywords

Community acquired methicillin resistant Staphylococcus aureus; Community associated methicillin resistant Staphylococcus aureus; Emergency department; Skin and soft tissue infections

Indexed keywords

EID: 77952004242     PISSN: 19314485     EISSN: None     Source Type: Journal    
DOI: 10.1097/TME.0b013e3181da402d     Document Type: Article

References (36)

1. Abrahamian, F. M., Talan, D. A., & Moran, G. J. (2008). Management of skin and soft-tissue infections in the emergency department. Infectious Disease Clinics of North America, 22, 89-116.
2. Archibald, L. K., Shapiro, J., Pass, A., Rand, K., & Southwick, F. (2008). Methicillin-resistant Staphylococcus aureus infection ina college football team: Risk factors outside the locker room and playing field. Infectious Control Hospital Epidemiology, 29 (5), 450-453.
3. Begier, E. M., Frenette, K., Barrett, N. L., Mshar, P., Petit, S., Boxrud, D. J.,...; Connecticut Bioterrorism Field Epidemiology Response Team. (2004). A high-morbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns. Clinical Infectious Diseases, 39 (10), 1446-1453.
4. Bucko, A. D., Hunt, B. J., Kidd, S. L., & Hom, R. (2002). Randomized, double-blind, multicenter comparison of oral cefditoren 200 or 400 mg BID with either cefuroxime 250 mg BID or cefadroxil 500 mg BID for the treatment of uncomplicated skin and skin-structure infections. Clinical Therapeutics, 24 (7), 1134-1147.
5. Cenizal, M. J., Skiest, D., Luber, S., Bedimo, R., Davis, P., Fox, P.,...; Hardy, R. D. (2007). Prospective randomized trial of empiric therapy with trimethoprimsulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy, 51 (7), 2628-2630.
6. Centers for Disease Control and Prevention. (2003a). Public health dispatch: outbreaks of communityassociated methicillin-resistant Staphylococcus aureus skin infections-Los Angeles County, California, 2002-2003. MMWR Weekly, 52 (33), 793-795. Retrieved September 15, 2008, from http://www.cdc. gov/mmwr/preview/mmwrhtml/mm5205a4.htm
7. Centers for Disease Control and Prevention. (2003b). Methicillin- resistant Staphylococcus aureus infections among competitive sports participants-Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. MMWR Weekly, 52 (05), 88. Retrieved September 27, 2008, from http://www.cdc. gov/mmwr/preview/mmwrhtml/mm5233a4.htm
8. Centers for Disease Control and Prevention. (2005). Community-associated MRSA information for clinicians. Retrieved June 4, 2008, from http://www.cdc.gov/ncidod/dhqp/ar mrsa ca clinicians.html
9. Centers for Disease Control and Prevention. (2007, September). Treatment algorithm for skin and soft tissue infections. Retrieved October 15, 2008, from http://www.cdc.gov/mrsa/mrsa initiative/skin infection/mrsa algorithm.html.
10. Davis, S. L., Perri, M. B., Donabedian, S. M., Manierski, C., Singh, A., Vager, D.,...; Zervos, M. J. (2007). Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection. Journal of Clinical Microbiology, 45 (6), 1705-1711.
11. Frazee, B. W., Lynn, J., Charlebois, E. D., Lambert, L., Lowery, D., & Perdreau-Remington, F. (2005). High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Annals of Emergency Medicine, 45 (3), 311-320.
12. Fridkin, S. K., Hageman, J. C., Morrison, M., Sanza, L. T., Como-Sabetti, K., Jernigan, J. A.,...; Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. (2005). Methicillin-resistant Staphylococcus aureus disease in three communities. The New England Journal of Medicine, 352 (14), 1436-1444.
13. Gordon, R. J., & Lowy, F. D. (2005). Bacterial infections in drug users. New England Journal of Medicine, 353, 1945-1954.
14. Gorwitz, R. J. (2008). A review of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. The Pediatric Infectious Disease Journal, 27 (1), 1-7.
15. Gorwitz, R. J., Jernigan, D. B., Powers, J. H., Jernigan, J. A., & Participants in the Centers of Disease Control and Prevention-Convened Experts Meeting on Management of MRSA in the Community. (2006). Strategies for clinical management of MRSA in the community: Summary of an experts' meeting convened by the Centers for Disease Control and Prevention. Retrieved September 27, 2008, from www.cdc.gov/ncidod/dhqp/pdf/ar/CAMRSA ExpMtgStrategiespdf
16. Hasty, M. B., Klasner, A., Kness, S., Dermark, T. K., Ellis, D., Herman, M. I., et al. (2007). Cutaneous community-associated methicillin-resistant staphylococcus aureus among all skin and soft-tissue infections in two geographically distant pediatric emergency departments. Academic Emergency Medicine, 14, 35-40.
17. Hersh, A. L., Chambers, H. F., Maselli, J. H., & Gonzales, R. (2008). National Trends in Ambulatory Visits and Antibiotic Prescribing for Skin and Soft Tissue Infections. Archives of Internal Medicine, 168 (14), 1585-1591.
18. Infectious Diseases Society of America. (in press). Management of patients with infections caused by methicillin-resistant Staphylococcus aureus: Clinical practice guidelines by the Infectious Diseases Society of America. Retrieved November 1, 2008, from http://www.idsociety.org/content.aspx?id= 4432#mrsa
19. Iyer, S., & Jones, D. H. (2004). Community-acquired methicillin-resistant Staphylococcus aureus skin infection: A retrospective analysis of clinical presentation and treatment of a local outbreak. Journal of the American Academy of Dermatology, 50 (6), 854-858.
20. Jacobus, C. H., Lindsell, C. J., Leach, S. D., Fermann, G. J., Kressel, A. B., & Rue, L. E. (2007). Prevalence and demographics of methicillin resistant Staphylococcus aureus in culturable skin and soft tissue infections in an urban emergency department. BioMed Central Emergency Medicine, 7 (19), 1-7.
21. Lee, M. C., Rios, A. M., Aten, M. F., Mejias, A., Cavuoti, D., McCracken, G. H., Jr., et al. (2004). Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillinresistant Staphylococcus aureus. The Pediatric Infectious Disease Journal, 23 (2), 123-127.
22. Miller, L. G., Perdreau-Remington, F., Bayer, A. S., Diep, B., Tan, N., Bharadwa, K.,...; Spellberg, B. (2007). Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillinsusceptible S. aureus infection: A prospective investigation. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 44 (4), 471-482.
23. Moran, G. J., Amii, R. N., Abrahamian, F. M., & Talan, D. A. (2005). Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerging Infectious Diseases, 11 (6), 928-930.
24. Moran, G. J., Krishnadasan, A., Gorwitz, R. J., Fosheim, G. E., McDougal, L. K., Carey, R. B.,...; Talan, D. A. (2006). Methicillin-resistant S. aureus infections among patients in the emergency department. The New England Journal of Medicine, 355 (7), 666-674.
25. Mosby's Medical, Nursing & Allied Health Dictionary. (1998). New York, NY: Mosby.
26. Naimi, T. S., LeDell, K. H., Como-Sabetti, K., Borchardt, S. M., Boxrud, D. J., Etienne, J.,...; Lynfield, R. (2003). Comparison of community-and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA: The Journal of the American Medical Association, 290 (22), 2976-2984.
27. Pallin, D. J., Egan, D. J., Pelletier, A. J., Espinola, J. A., Hooper, D. C., & Camargo, C. A., Jr. (2008). Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of communityassociated methicillin-resistant Staphylococcus aureus. Annals of Emergency Medicine, 51 (3), 291-298.
28. Paydar, K. Z., Hansen, S. L., Charlebois, E. D., Harris, H. W., & Young, D. M. (2006). Inappropriate antibiotic use in soft tissue infections. Archives of Surgery (Chicago, Ill.: 1960), 141 (9), 850-854;
29. discussion 855-856.
30. Popvich, K. J., & Hota, B. (2008). Treatment and prevention of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Dermatologic Therapy, 21, 167-179.
31. Rajendran, P. M., Young, D., Maurer, T., Chambers, H., Perdreau-Remington, F., Ro, P.,...; Harris, H. (2007). Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection. Antimicrobial Agents and Chemotherapy, 51 (11), 4044-4048.
32. Romano, R., Lu, D., & Holton, P. (2006). Outbreak of community-acquired methicillin-resistant Staphylococcus aureus skin infections among a collegiate football team. Journal of Athletic Training, 41 (2), 141-145.
33. Ruhe, J. J., Smith, N., Bradsher, R. W., & Menon, A. (2007). Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: Impact of antimicrobial therapy on outcome. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 44 (6), 777-784.
34. Sattler, C. A., Mason, E. O., Jr., & Kaplan, S. L. (2002). Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatric Infectious Diseases Journal, 21 (10), 910-917.
35. Stevens, D. L., Bisno, A. L., Chambers, H. F., Everett, E. D., Dellinger, P., Goldstein, E. J.,...; Wade, J. C. (2005). Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 41 (10), 1373-1406.
36. Stryjewski, M. E., & Chambers, H. F. (2008). Skin and soft tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus. Clinical Infectious Diseases, 46 (11), S368-S377.